TG Therapeutics
TGTX
$18.58
Share price
-3.18%
Change (1 day)
-18.76%
Change (1 year)
Categories
Operating Margin for TG Therapeutics (TGTX)
Operating Margin as of June 2024 (TTM): -7,121.54%
According to TG Therapeutics's latest financial reports and stock price the company's current Operating Margin is -7,121.54%. At the end of 2022 the company had an Operating Margin of -7,121.54%.
Operating Margin history for TG Therapeutics from 2001 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | -7,121.54% | 36.85% |
| 2021 | -5,204.08% | -97.17% |
| 2020 | -183,803.29% | 61.61% |
| 2019 | -113,730.92% | -0.35% |
| 2018 | -114,132.89% | 46.79% |
| 2017 | -77,749.86% | 51.4% |
| 2016 | -51,353.45% | 24.31% |
| 2015 | -41,310.04% | 12.85% |
| 2014 | -36,606.45% | 172.39% |
| 2013 | -13,438.82% | -90.1% |
| 2012 | -135,725.28% | |
| 2002 | -310.58% | 171.06% |
| 2001 | -114.58% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Alkermes ALKS | -15.04% | -99.79% | 🇮🇪 Ireland |
 Dr. Reddy's RDY | 24.69% | -100.35% | 🇮🇳 India |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.